(Total Views: 80)
Posted On: 09/25/2017 10:21:23 PM
Post# of 106694
$RCHA NEW AUDITOR! On Sep 18, 2017, filed an 8-K with the SEC stating that RCHA had dismissed their old Auditor to hire/engage Anton & Chia, LLP as their new Auditor which I believe will help HPGN to trade on the NASDAQ
HypGen uses Rich's phorbol esters IP in PD indication
Aug 2017
Executive Summary
HypGen Inc. (formerly Mega Bridge Inc.) will use Rich Pharmaceuticals Inc.'s intellectual property related to 12-O-tetradecanoylphorbol-13-acetate (TPA) to develop Parkinson's disease (PD) therapeutics.
https://scrip.pharmamedtechbi.com/deals/201720373
HypGen uses Rich's phorbol esters IP in PD indication
Aug 2017
Executive Summary
HypGen Inc. (formerly Mega Bridge Inc.) will use Rich Pharmaceuticals Inc.'s intellectual property related to 12-O-tetradecanoylphorbol-13-acetate (TPA) to develop Parkinson's disease (PD) therapeutics.
https://scrip.pharmamedtechbi.com/deals/201720373
(0)
(0)
